Chicken interferon types I and II enhance synergistically the antiviral state and nitric oxide secretion

Journal of Interferon and Cytokine Research

Volumn 18, Issue 6, 1998, Pages 407-414

  Sekellick, Margaret J ^a   Lowenthal, John W ^b   O'Neil, Terri E ^b   Marcus, Philip I ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; RECOMBINANT INTERFERON;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CHICK EMBRYO; CYTOKINE PRODUCTION; CYTOPATHOGENIC EFFECT; DOSE RESPONSE; EMBRYO; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; GALLUS GALLUS; MAMMALIA;

EID: 0031859172     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1998.18.407     Document Type: Article

References (35)

1. FLEISCHMANN, W.R., GEORGIADES, J.A., OSBORNE, L.C., and JOHNSON, H.M. (1979). Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon. Infect. Immun. 26, 248-253.
2. SCHWARZ, L.A., and FLEISCHMANN, W.R., Jr. (1981/82). Potentiation of interferon action. Tex. Rep. Biol. Med. 41, 298-305.
3. OLESZAK, E., and STEWART, W.E. II. (1985). Potentiation of the antiviral and anticellular activities of interferons by mixtures of HuIFN-gamma and HuIFN-alpha or HuIFN-beta. J. Interferon Res. 5, 361-371.
4. FLEISCHMANN, W.R. Jr. (1997). Priming of interferon action. Tex. Rep. Med. Biol. 35, 316-325.
5. CZARNIECKI, C.W., FENNIE, C.W., POWERS, D.B., and ESTELL, D.A. (1984). Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta and gamma interferons. J. Virol. 49, 490-496.
6. OZZELLO, L., HABIF, D.V., DE ROSA, C.M., and CANTELL, K. (1988). Treatment of human breast cancer xenografts using natural interferon-alpha and -gamma injected singly or in combination. J. Interferon Res. 8, 679-690.
7. FLEISCHMANN, W.R., Jr., KLEYN, K.M., and BARON, S. (1980). Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations. J. Natl. Cancer Inst. 65, 963-966.
8. FLEISCHMANN, W.R., Jr., SCHWARZ, L.A., and FLEISCHMANN, C.M. (1984). Requirement for interferon gamma in potentiation of interferons antiviral and anticellular activities: identity of mouse and human system. J. Interferon Res. 4, 265-274.
9. DECLERCQ, E., ZHANG, Z.-X., and HUYGER, K. (1982). synergism in the antitumor effects of type I and type II interferon in mice inoculated with leukemia L1210 cells. Cancer Lett. 15, 223-228.
10. WEIGANT, D.A., LANGFORD, M.P., FLEISCHMANN, W.R., Jr., and STANTON, G.J. (1983). Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon. Infect. Immun. 40, 35-38.
11. SEKELLICK, M.J., FERRANDINO, A.F., HOPKINS, D.A., and MARCUS, P.I. (1994). Chicken interferon gene: cloning, expression, and analysis. J. Interferon Res. 14, 71-79.
12. DIGBY, M.R., and LOWENTHAL, J.W. (1995). Cloning and expression of the chicken interferon-gamma gene. J. Interferon Cytokine Res. 15, 939-945.
13. SEN, G.C., and RANSOHOFF, R.M. (1997). Transcriptional Regulation in the Interferon System. New York: Chapman & Hall.
14. BEUG, H., VON KIRCHENBACH, A., DODERLEIN, G., CONSCIENCE, J.-F., and GRAF T. (1979). Chicken hemopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation. Cell 18, 375-390.
15. SEKELLICK, M.J., BIGGERS, W.J., and MARCUS, P.I. (1990). Development of the interferon system. I. In chicken cells development in ovo continues on time in vitro. In Vitro Cell. Dev. Biol. 26, 997-1003.
16. LOWENTHAL, J.W., DIGBY, M.R., and YORK, J.J. (1995). Production of interferon-gamma by chicken T cells. J. Interferon Cytokine Res. 15, 933-938.
17. SEKELLICK, M.J., and MARCUS, P.I. (1986). Induction of high titer chick interferon. Methods Enzymol. 119, 115-125.
18. LOWENTHAL, J.W., CONNICK, T.E., MCWATERS, P.G., and YORK, J.J. (1994). Development of T cell immune responsiveness in the chicken. Immunol. Cell Biol. 72, 115-122.
19. HOPKINS, D.A. (1995). Characterization of a Recombinant Chicken Interferon. M.S. Thesis, University of Connecticut, Storrs.
20. LOWENTHAL, J.W., YORK, J.J., O'NEIL, T.E., RHODES, S., PROWSE, S.J., STROM, A.D.G., and DIGBY, M.R. (1997). In vivo effects of chicken interferon-γ during infection with Eimeria. J. Interferon Cytokine Res. 17, 551-558.
21. KOYAMA, A.H. (1995). Induction of apoptotic DNA fragmentation by the infection of vesicular stomatitis virus. Virus Res. 37, 285-290.
22. MARCUS, P.I., RODRIGUEZ, L.L., and SEKELLICK, M.J. (1998). Interferon induction as a quasispecies marker of vesicular stomatitis virus populations. J. Virol. 72, 542-549.
23. DIANZANI, F., SALTER, L., FLEISCHMANN, W.R. Jr., and ZUCCA, M. (1978). Immune interferon activates cells more slowly than does virus-induced interferon. Proc. Soc. Exp. Biol. Med. 159, 94-97.
24. XIE, Q.-W., CHO, H.J., CALAYCAY, J., MUMFORD, R.A., SWIDEREK, K.M., LEE, T.D., DING, A., TROSO, T., and NATHAN, C. (1992). Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256, 225-228.
25. SCHULTZ, U., KASPERS, B., RINDERLE, C., SEKELLICK, M.J., MARCUS, P.I., and STAEHELI, P. (1995). Recombinant chicken interferon: a potent antiviral agent that lacks intrinsic macrophage activating factor. Eur. J. Immunol. 25, 847-851.
26. SCHWARZ, L.A., and FLEISCHMANN, W.R. Jr. (1983). Interferon potentiation occurs at a pretranscriptive stage. Infect. Imun. 39, 159-163.
27. LEVY, D.E., LEW, D.J., DECKER, T., KESSLER, D.S., and DARNELL, J.E. Jr. (1990). Synergistic interaction between interferon-α and interferon-γ through induced synthesis of one subunit of the transcription factor ISGF3. EMBO J. 9, 1105-1111.
28. SCHINDLER, C., FU, X.-Y., IMPROTA, T., AEBERSOLD, R., and DARNELL, J.E. JR. (1992). Proteins of transcription factor ISGF-3: one gene encodes the 91- and 84-kDa ISGF-3 proteins that are activated by interferon. Proc. Natl. Acad. Sci. USA 89, 7836-7839.
29. GOODBOURN, S., ZINN, K., and MANIATIS, T. (1986). The human β-interferon gene expression is regulated by an inducible enhancer. Cell 41, 509-520.
30. DE LA TORRE, J.C., and HOLLAND, J.J. (1990). RNA virus quasispecies populations can suppress vastly superior mutant progeny. J. Virol. 64, 6278-6281.
31. MARCUS, P.I., and SEKELLICK, M.J. (1988). Interferon induction by viruses. XVI. 2-Aminopurine blocks selectively and reversibly an early stage in interferon induction. J. Gen. Virol. 69, 1637-1645.
32. FAST, D.J., LYNCH, R.C., and LEU, R.W. (1993). Interferon-gamma, but not interferon-alpha/beta, synergizes with tumor necrosis factor-alpha and lipid A in the induction of nitric oxide production by murine L929 cells. J. Interferon Res. 13, 271-277.
33. DECKER, T., KOVARIK, P., and MEINKE, A. (1997). Gas elements: a few nucleotides with a major impact on cytokine-induced gene expression. J. Interferon Cytokine Res. 17, 121-134.
34. BARON, S., and ISAACS, A. (1961). Mechanism of recovery from viral infections in the chick embryo. Nature 191, 97-98.
35. FLEISCHMANN, W.R., MASOOR, J. Jr., WU, T.Y., and FLEISCHMANN, C.M. (1998). Orally administered IFN-α alone and in synergistic combination with intraperitoneally administered IFN-γ to exert an antitumor effect against B16 melanoma in mice. J. Interferon Cytokine Res. 18, 17-21.